Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease (Q58272064)

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

21 January 2018

The Lung's Quiet Zone

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The small airways and distal lung compartment in asthma and COPD: a time for reappraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The importance and features of the distal airways in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The outer wall of small airways is a major site of remodeling in fatal asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Pulmonary periarterial inflammation in fatal asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Differential distribution of inflammatory cells in large and small airways in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Inflammatory cell distribution within and along asthmatic airways.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Multimodality measurements of small airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Tumour necrosis factor-alpha production in human alveolar macrophages: modulation by inhaled corticosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Induced sputum for the investigation of airway inflammation: evidence for its clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Imaging of the distal airways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Positron emission tomography imaging of regional pulmonary perfusion and ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Validation of computational fluid dynamics in CT-based airway models with SPECT/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Imaging the lungs in patients with pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Decreased computed tomographic lung density during exacerbation of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Quantitative CT in chronic obstructive pulmonary disease: inspiratory and expiratory assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Functional significance of air trapping detected in moderate asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Quantitative assessment of air trapping in chronic obstructive pulmonary disease using inspiratory and expiratory volumetric MDCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Air trapping in mild and moderate asthma: effect of inhaled corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Hyperpolarized 3-helium magnetic resonance imaging to probe lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Helium-3 MRI diffusion coefficient: correlation to morphometry in a model of mild emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Assessment of the lung microstructure in patients with asthma using hyperpolarized 3He diffusion MRI at two time scales: comparison with healthy subjects and patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Tests of forced expiration and inspiration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The clinical importance of dynamic lung hyperinflation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Forty years of closing volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Nitrogen washout slope in poorly controlled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Frequency dependence of compliance as a test for obstruction in the small airways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Small airways: a time to revisit?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Current Status of Small Airways Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Exhaled nitric oxide in pulmonary diseases: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Central and peripheral airway/alveolar sites of exhaled nitric oxide in acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Central and peripheral airway sites of nitric oxide gas exchange in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Nonreversible conductive airway ventilation heterogeneity in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Clinical applications of forced oscillation to assess peripheral airway function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Assessment of reversibility of airflow obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Fluctuations and determinism of respiratory impedance in asthma and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The influence of lung deposition on clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Alveolar and airway sites of nitric oxide inflammation in treated asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The functional benefit of anti-inflammatory aerosols in the lung periphery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Ciclesonide improves measures of small airway involvement in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

The safety of tiotropium--the FDA's conclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.585656